Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
activities of daily living
activities of daily living scale
adverse drug reaction
agitation
akathisia
alpha methyldopa hydrazine
Alzheimer's disease
amiodarone
amphotericin B
anticholinergic drugs
anticonvulsants
anticonvulsants, cognitive function with
anticonvulsants, untoward effects of
antidepressant
anxiolytic agents
asterixis
ataxia
ataxia, cerebellar
ataxia, truncal
ataxic gait
autonomic dysfunction
basal ganglia
basal ganglia, lesion of
benign essential tremor
bethanechol
bradykinesia
brain transplantation
burning paresthesia
buspirone
butyrophenone
calcium antagonist
calcium antagonist, side effects of
CAT scan
CAT scan, abnormal
CAT scan, contrast enhanced
CAT scan, emission
CAT scan, emission, abnormal
central nervous system, infection of
cerebrospinal fluid, MHPG(3-methoxy 4-hydroxyphenyl glycol)
cerebrovascular accident
cerebrovascular accident, acute management of
chemotherapy, CNS treatment and complications with
chlorpromazine
cholinergic drug
chorea
cinnarizine
clozapine
cognition
complications
contrast agents, neurotoxicity of
creatine phosphokinase(CPK)elevated
cyanide poison
dementia
depression
diltiazem
diplopia
diquat
disulfiram
dopamine antagonist
drug abuse
drug abuse, neurologic complications of
drug induced neurologic disorders
drug interactions
drug overdose
dyskinesia
dyskinesia, buccal lingual facial
dystonia
dystonia, drug induced
dystonic reaction, acute
ecstasy
emergencies, neurologic
emergency room
encephalopathy
enzyme inhibition
epidemiology of neurology
facial movement disorder
falling
fetal tissue
fever
flunarizine
fluorouracil
fluoxetine
fluvoxamine
GM1 ganglioside
haloperidol
headache
headache, treatment of
hemiballismus
hemichorea
herbicide
hexane
HMGcoA reductase inhibitors
huffing
human immunodeficiency virus type 1
Huntington's chorea
hyperthermia
iatrogenic neurologic disorders
inclusion bodies, eosinophilic cytoplasmic
intellectual deficit
L-dopa
L-dopa, potentiators of
lenticular nucleus, lesion of
lenticular nucleus, lesion of, bilateral
Lewy body
Lewy body disease, diffuse
lipid lowering agent
lithium
locus ceruleus, lesion of
lovastatin
manganese intoxication
medical-legal aspects of neurology
memory, impairment of
mental status, abnormal
meperidine
metoclopramide
migraine, prophylaxis
migraine, treatment of
misdiagnosis
mortality
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
movement disorder, treatment of
MPTP
MRI
MRI, abnormal
multiple system atrophy
myoclonus
naproxen
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neuropathology
neuropathology, brain
neuroprotective agents
neurotoxic
neurotoxin
nonsteroidal anti-inflammatory drug
nursing home
nystagmus
occupational neurologic disorders
octreotide
olanzapine
old age, neurology of
ophthalmoplegia
paresthesias
paresthesias, facial
Parkinson disease
Parkinson disease, arteriosclerotic
Parkinson disease, diagnosis
Parkinson disease, differential diagnosis of
Parkinson disease, drug induced
Parkinson disease, exacerbation
Parkinson disease, misdiagnosis
Parkinson disease, progression
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
Parkinson disease, unmasked
Parkinsonism hyperpyrexia syndrome
Parkinsonism multiple-system atrophy
Parkinsonism syndrome
paroxetine
paroxysmal nonkinesigenic dyskinesia
phenothiazine
poison, neurologic problems with
prognosis
progressive supranuclear palsy
psychiatric disorder
psychiatric problems in neurologic disorders
psychosis
putamen, lesion of
putamen, lesion of, bilateral
quetiapine
Rabbit syndrome
renal failure
review article
rhabdomyolysis
rigidity
risperidone
seizure
seizure, treatment of
selective serotonin reuptake inhibitors
serotonin syndrome
sertraline
sinemet
single photon emission computed tomography
sodium valproate
sodium valproate, toxicity
solvent
stridor
subarachnoid hemorrhage
subarachnoid hemorrhage, treatment of
substantia nigra tissue
tardive dyskinesia
tardive dyskinesia, treatment of
tardive dystonia
tetrabenazine
tic
toxins, nervous system
transient neurologic deficit
treatment of neurologic disorder
tremor
tremor, jaw
tricyclic antidepressant
vasospasm, cerebral
verapamil
vision, blurred
wheelchair
Showing articles 100 to 150 of 1590 << Previous Next >>

Rapidly Progressive Thalamic Dementia
Neurol 96:e809-e813, Rizzo, A.C.,et al, 2021

The 5 Pillars in Tourette Syndrome Deep Brain Stimulation Patient Selection
Neurol 96:664-676, Martino, D.,et al, 2021

Beware of Deep Water After Subthalamic Deep Brain Stimulation
Neurol 94:39-41, Waldvogel, D.,et al, 2020

Diagnosis and Treatment of Parkinson Disease
JAMA 323:548-560, Armstrong, M.J. & Okun, M.S., 2020

Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinsons Disease
NEJM 382:1926-1932, Schweitzer, J.S.,et al, 2020

Vitamin B6 Deficiency Presenting with New-Onset Epilepsy and Status Epilepticus in a Patient with Parkinson Disease
Neurol 94:e2605-e2607, Modica, J.S.,et al, 2020

Deep Brain Stimulation in Early-Stage Parkinson Disease
Neurol 95:e393-e401,e431, Hacker, M.L.,et al, 2020

Muscle Stiffness, Gait Instability, and Liver Cirrhosis in Wilsons Disease
Lancet 396:990, Kronlage, C.,et al, 2020

Non-Motor Symptoms in Parkinsons Disease are Reduced by Nabilone
Ann Neurol 88:712-722, Peball, M.,et al, 2020

Involuntary Groaning Induced by Levodopa Therapy in a Patient With Progressive Supranuclear Palsy
JAMA Neurol 77:1569, Park, J.E., 2020

Randomized Trial of Focused Ultrasound Subthalamotomy for Parkinsons Disease
NEJM 383:2501-2513,2582, Martinez-Fernandez, R.,et al, 2020

MR Imaging of the Brain in Neurologic Wilson Disease
AJNR 40:178-183, Yu, X.-E.,et al, 2019

Clinicopathologic Conference, Powassan Virus Encephalitis
NEJM 380:380-387, Case 3-2019, 2019

When to Start Levodopa Therapy for Parkinsons Disease
NEJM 380:389-390, Bressman, S. & Saunders-Pullman, R., 2019

Serum NFL discriminates Parkinson Disease from Atypical Parkinsonisms
Neurol 92:e1479-e1486, Marques, T.M.,et al, 2019

Placebo-Controlled, Randomized, Double-Blind Study of IncobotulinumtoxinA for Sialorrhea
Neurol 92:e1982-e1991, Jost, W.H.,et al, 2019

Treatment of Tics in People with Tourette Syndrome and Chronic Tic Disorders
Neurol 92:896-906, Pringsheim, T.,et al, 2019

Suicide and Suicide Attempts after Subthalamic Nucleus Stimulation in Parkinson Disease
Neurol 93:e97-e105, Giannini, G.,et al, 2019

A 58-year-old Man with Hand Tremor and Episodes of Neck Pain
Neurol 93:557-561, Urso, D.,et al, 2019

Stridor in Multiple System Atrophy
Neurol 93:630-639, Cortelli, P.,et al, 2019

Tics and Functional Tic-Like Movements
Neurol 93:750-758, Ganos, C.,et al, 2019

Three-year Follow-up of Prospective Trial of Focused Ultrasound Thalamotomy for Essential Tremor
Neurol 93:e2284-e2293, Halpern, C.H.,et al, 2019

Neurodegeneration with Brain Iron Accumulation
AIAN 22:267-276, Batla, A. & Gaddipati, C., 2019

Basa Ganglia Calcifications (Fahrs Syndrome): Related Conditions and Clinical Features
Neurol Sci 40:2251-2263, Donzuso,G.,et al, 2019

Bilateral Basal Ganglia Necrosis Secondary to Methamphetamine
MDCP 5:55-556, Sanchez,A. et al, 2018

Cerebral Atrophy and Leukoencephalopathy in a Young Man Presenting with Encephalitic Episodes
JAMA Neurol 75:1563-1564, Xiao, F.,et al, 2018

The Laser Shoes
Neurol 90:e164-e171, Barthel, C.,et al, 2018

The Parkinson Pandemic - A Call to Action
JAMA Neurol 75:9-10, Dorsey, E.R. & Bloem, B.R., 2018

Efficacy and Safety of Deep Brain Stimulation in Tourette Syndrome
JAMA Neurol 75:353-359, Martinez-Ramirez, D.,et al, 2018

Cranial Cavernous Malformations
Stroke 49:1029-1035, Stapleton, C.J. & Barker, F.G., 2018

A 75-year-old man with parkinsonism, mood depression, and weight loss
Neurol 90:572-575, Frattini, E.,et al, 2018

Essential Tremor
NEJM 378:1802-1810, Haubenberger, D.,et al, 2018

Atypical Parkinsonian Syndromes: A General Neurologists Perspective
Eur J Neurol 25:41-58, Deutschlander, A.B.,et al, 2018

Advances in Progressive Supranuclear Palsy: New Diagnostic Criteria, Biomarkers, and Therapeutic Approaches
Lancet Neurol 16:552-563, Boxer, A.L.,et al, 2017

Successful Management of Super-Refractory Status Epilepticus with Thalamic Deep Brain Stimulation
Ann Neurol 81:142-146, Lehtimaki, K.,et al, 2017

Blood-based NfL - A biomarker for differential diagnosis of parkinsonian disorder
Neurol 88:930-937,922, Hansson, O.,et al, 2017

Viral Hepatitis and Parkinson Disease
Neurol 88:1630-1633, Pakpoor, J.,et al, 2017

Clinical Manifestations of the anti-IgLON5 Disease
Neurol 88:1736-1743,1688, Gaig, C.,et al, 2017

Precipitous Deterioration of Motor Function, Cognition, and Behavior
JAMA Neurol 74:591-596, Fernandez-Fournier, M.,et al, 2017

A 58-year-old man with Progressive Ptosis and Walking Difficulty
Neurol 89:e1-e5, Kuo, P.,et al, 2017

Diagnosis and Management of Dementia with Lewy Bodies
Neurol 89:88-100, McKeith, I.G.,et al, 2017

A Demure Teenager and Her Dystonic Foot
Neurol 89:e71-e75, Cullinane, P.W.,et al, 2017

Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Court
JAMA Neurol 74:933-940,901, Jennings, D.,et al, 2017

Thalamic Deep Brain Stimulation for Tremor in Parkinson Disease, Essential Tremor, and Dystonia
Neurol 89:1416-1423, Cury, R.G.,et al, 2017

National Randomized Controlled Trial of Virtual House Calls for Parkinson Disease
Neurol 89:1152-1161,1103, Beck, C.A.,et al, 2017

MRI of the Swallow Tail Sign: A Useful Marker in the Diagnosis of Lewy Body Dementia?
AJNR 38:1737-1741, Shams, S.,et al, 2017

Management of Parkinson Disease in 2017
JAMA 318:791-792, Okun, M.S.,et al, 2017

A 55-year-old Man with Rapidly Progressive Dementia and Parkinsonism
Neurol 89:e182-e187, Tabuas-Pereira, M.,et al, 2017

An 82-year-old man with Worsening Gait
Neurol 89:e246-e252, Chew, S.,et al, 2017

Early Weight Loss in Parkinsonism Predicts Poor Outcomes
Neurol 89:2254-2261, Cumming, K.,et al, 2017



Showing articles 100 to 150 of 1590 << Previous Next >>